⌘K
Loading ticker…
As of 2026-08-24, Agios Pharmaceuticals, Inc. (AGIO) has a 3-month relative strength percentile of 76 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.1%, relative volume 0.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
AGIO is held by 29 ETFs as of May 2026. Top owner: VTWO at 0.05% weight, $9M notional. Top 3 carry $22M.
Held by 68 ETFs · $359M across latest filings · largest weight 1.64% (BBP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.05% | $9M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.04% | $8M | — |
| VHTVanguard Health Care ETF | 0.03% | $5M | — |
| AVSC | 0.12% | $3M | — |
| SBIO | 1.10% | $2M | −0.04 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.10% |
| $1M |
| −0.01 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
| ONEQ | 0.01% | $738K | — |
| ISMD | 0.14% | $454K | −0.06 pp |
| ESGV | 0.00% | $370K | — |
Showing 10 of 29 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AGIO Jan avg: 3.00% median: 3.11% win: 100% σ: 2.12% n: 4 2022-04-12 → 2026-07-31 | AGIO Feb avg: 10.56% median: 6.76% win: 75% σ: 23.86% n: 4 2022-04-12 → 2026-07-31 | AGIO Mar avg: -6.11% median: -9.39% win: 25% σ: 12.61% n: 4 2022-04-12 → 2026-07-31 | AGIO Apr avg: -5.76% median: -0.43% win: 40% σ: 14.27% n: 5 2022-04-12 → 2026-07-31 | AGIO May avg: 4.81% median: 8.08% win: 80% σ: 9.42% n: 5 2022-04-12 → 2026-07-31 | AGIO Jun avg: 14.88% median: 13.87% win: 100% σ: 8.34% n: 5 2022-04-12 → 2026-07-31 | AGIO Jul avg: -1.73% median: -2.71% win: 40% σ: 12.22% n: 5 2022-04-12 → 2026-07-31 | AGIO Aug avg: 5.48% median: 2.37% win: 75% σ: 8.69% n: 4 2022-04-12 → 2026-07-31 (current) | AGIO Sep avg: 1.09% median: 1.61% win: 50% σ: 9.34% n: 4 2022-04-12 → 2026-07-31 | AGIO Oct avg: -2.50% median: -1.31% win: 25% σ: 9.48% n: 4 2022-04-12 → 2026-07-31 | AGIO Nov avg: 4.11% median: 7.62% win: 75% σ: 27.35% n: 4 2022-04-12 → 2026-07-31 | AGIO Dec avg: -14.53% median: -6.81% win: 25% σ: 20.36% n: 4 2022-04-12 → 2026-07-31 |